KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Treasury Shares: 2009-2024

Historic Treasury Shares for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $3.1 billion.

  • Chemed's Treasury Shares rose 1810.56% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year increase of 1810.56%. This contributed to the annual value of $3.1 billion for FY2024, which is 1496.81% up from last year.
  • Per Chemed's latest filing, its Treasury Shares stood at $22.9 million for FY2024, which was up 323.68% from $22.1 million recorded in FY2023.
  • Chemed's 5-year Treasury Shares high stood at $22.9 million for FY2024, and its period low was $232500.0 during FY2022.
  • Its 5-year average for Treasury Shares is $9.4 million, with a median of $1.2 million in 2021.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 3333.27% in 2021, then surged by 507.87% in 2023.
  • Chemed's Treasury Shares (Annual) stood at $1.8 billion in 2020, then soared by 33.33% to $2.4 billion in 2021, then increased by 6.5% to $2.6 billion in 2022, then grew by 5.08% to $2.7 billion in 2023, then increased by 14.97% to $3.1 billion in 2024.
  • Its Treasury Shares stands at $3.1 billion for FY2024, versus $2.7 billion for FY2023 and $2.6 billion for FY2022.